Best of ASCO - 2014 Annual Meeting

 

Welcome

Other (Salivary, Thyroid)

Head and Neck Cancer

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A novel prognostic risk classification model for NUT midline carcinoma: a largest cohort analysis from the NMC registry.

Nicole Grace Chau

6085

A phase II trial of cabozantinib (CABO) for the treatment of radioiodine (RAI)-refractory differentiated thyroid carcinoma (DTC) in the first-line setting.

Marcia S. Brose

6088

A prospective observational multicentric pan India study of lenvatinib in radio-iodine refractory advanced differentiated thyroid cancer.

S.P. Somashekhar

e18106

A randomized doubled blind phase II study exploring the safety and efficacy of nintedanib (BIBF1120) as second line therapy for patients (pts) with differentiated thyroid carcinoma (DTC) progressing after first line therapy: EORTC 1209.

Martin Schlumberger

6021

An exploratory phase II clinical trial of apatinib in progressive radioiodine refractory differentiated thyroid cancer.

Yan-Song Lin

e18094

An open-label, randomized phase III trial of gemcitabine and carboplatin (GC) followed by Epstein-Barr virus-specific autologous cytotoxic t lymphocytes (EBV-CTLs) versus GC as front-line therapy for patients (pts) with advanced nasopharyngeal carcinoma (NPC).

Han Chong Toh

6082

Apatinib plus radiotherapy or not in chemotherapy-refractory recurrent or metastatic oral squamous cell carcinoma: A pilot study.

Hui Wu

e18101

Atypia of undetermined significance in thyroid fine-needle aspiration cytology: Clinicopathological predictors of malignancy.

Soo Kyung Ahn

e18103

Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer.

Eric Jeffrey Sherman

6087

Comprehensive genomic profiling of anaplastic thyroid carcinoma.

Daniel W. Bowles

6089

Cytological method or PTH detection for rapid detection of parathyroid glands during thyroid surgery.

Hongliang Wei

e18091

Everolimus in anaplastic thyroid cancer: A case series.

Ethan James Harris

e18112

Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival.

Jennifer Rui Wang

6023

Genetic variants including microsatellite instability in metastatic Hürthle cell carcinoma of the thyroid.

Natalie Hale-Wallace

e18110

Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs androgen deprivation therapy (ADT) inpatients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (NCT01969578).

Laura Locati

TPS6099

Hydrolytic activity in tissues of tumors of the upper jaw.

Marina Engibaryan

e18096

Hypothyroidism to predict for long term survival in patients with fosbretabulin treated anaplastic thyroid carcinoma.

Deborah Blythe Doroshow

e18108

Impact of viral infection on effectiveness of antitumor treatment for laryngeal cancer.

Tatiana Zykova

e18098

Indian experience of lenvatinib in radio-iodine refractory differentiated thyroid cancer.

Satheesh Chiradoni Thungappa

e18107

Integrative whole-genome analysis of salivary duct carcinoma.

Sehhoon Park

6083

JAK inhibitors to suppress paclitaxel-resistant anaplastic thyroid cancer via IL-6 reduction.

Tomoyuki Fujita

e18093

Multivariate analysis on prognostic factors for intrathyroid papillary thyroid carcinoma.

Ivan Markovic

e18100

Novel approach for unresectable salivary duct carcinoma: Targeting HER2 and androgen receptor.

Daisuke Kawakita

6084

Parameters of lipid peroxidation in tumors of the upper jaw.

Yulia V. Ulianova

e18097

Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with anaplastic thyroid cancer.

Lori J. Wirth

6024

Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936).

Laura Locati

6086

Prevention of surgical site infection after oral cancer surgery by topical tetracycline: Results of a multicenter randomized control trial.

Madoka Funahara

6080

Radiotherapy to demonstrate persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid cancer.

Jennifer Ma

e18115

Recovery after long-term recurrent laryngeal nerve paralysis: Liberation surgical technique.

Radan Radoslav Dzodic

e18111

Relationship of anaplastic thyroid cancer high tumor mutation burden and MSI-H status with response to anti-PD1 monotherapy.

Saad A. Khan

e18114

Remote access thyroid surgery for thyroid tumor: Initial institutional experience more than 100 surgeries from India.

Gyan Chand

e18113

Role of sentinel lymph node biopsy using methylene blue dye for adequate intraoperative staging of medullary thyroid microcarcinomas: A single institution experience.

Nada Santrac

e18116

Second interim analysis of RIFTOS MKI, a global non-interventional study assessing the use of multikinase inhibitors (MKIs) in the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

Marcia S. Brose

6081

Ten years survival of differentiated thyroid cancer patients treatment without radio-iodine therapy.

Aynur Oktamovna Kenjaeva

e18092

Trends in thyroid cancer incidence in India.

Janeesh Sekkath Veedu

e18095